Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Change in Receivables (2023 - 2025)

Historic Change in Receivables for BioScience Health Innovations (BHIC) over the last 3 years, with Q3 2025 value amounting to -$326801.0.

  • BioScience Health Innovations' Change in Receivables fell 773018.91% to -$326801.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $31299.0, marking a year-over-year increase of 13716.75%. This contributed to the annual value of $63837.0 for FY2024, which is 12252.94% up from last year.
  • Latest data reveals that BioScience Health Innovations reported Change in Receivables of -$326801.0 as of Q3 2025, which was down 773018.91% from $296564.0 recorded in Q2 2025.
  • BioScience Health Innovations' Change in Receivables' 5-year high stood at $296564.0 during Q2 2025, with a 5-year trough of -$326801.0 in Q3 2025.
  • In the last 3 years, BioScience Health Innovations' Change in Receivables had a median value of $4283.0 in 2024 and averaged $5041.0.
  • Data for BioScience Health Innovations' Change in Receivables shows a peak YoY increase of 468483.38% (in 2025) and a maximum YoY decrease of 773018.91% (in 2025) over the last 5 years.
  • Over the past 3 years, BioScience Health Innovations' Change in Receivables (Quarter) stood at $17732.0 in 2023, then surged by 285.59% to $68372.0 in 2024, then tumbled by 577.97% to -$326801.0 in 2025.
  • Its Change in Receivables stands at -$326801.0 for Q3 2025, versus $296564.0 for Q2 2025 and -$6836.0 for Q1 2025.